🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementDizziness and orthostatic hypotension on GLP-1 — March 2026 Page 2

Dizziness and orthostatic hypotension on GLP-1 — March 2026

laura_annarbor Sat, Feb 22, 2025 at 11:09 AM 14 replies 1,814 viewsPage 2 of 3
Dr.PainCLE
Senior Member
1,234
6,234
Mar 2024
Cleveland, OH
Feb 22, 2025 at 11:42 PM#6
BenResearch_OR said:
The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the…

I dislike how confidently this board tells people to push through. Incidence figures around 20 to 25% at the higher doses are class-typical, but the trials also had a discontinuation column, and "manageable with protocols" is not the same as manageable for everyone.

3 23Dr.PathRoch, mona_PHX, andrew_nyc
Reply Quote Save Share Report
jason_paloalto
Member
212
890
Nov 2024
Palo Alto, CA
Feb 23, 2025 at 4:40 AM#7

The figures, for anyone assembling their own picture. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

2 22Dr.PathRoch, mona_PHX
Reply Quote Save Share Report
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Feb 23, 2025 at 9:38 AM#8
Dr.PainCLE said:
I dislike how confidently this board tells people to push through.

Adding the part of the answer the thread has not reached. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

1 21MikeKY_noInsulin
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TomTeleRx
Member
189
678
Feb 2025
Delaware
Feb 23, 2025 at 2:36 PM#9

Following on from FranDenver — and this may be the naive question:

Whether holding at a lower dose for longer actually reduces total side-effect burden or just spreads it out?

50 20HPLC_Greg, LibrarianMeg, bri_stats and 47 others
Reply Quote Save Share Report
laura_annarbor
Member
189
890
Dec 2024
Ann Arbor, MI
Feb 24, 2025 at 2:29 PM#10

OP back with an update, since a thread like this is useless without one.

Follow-up: smaller meals, less fat in the two days after dosing, and not lying down afterwards. Unglamorous, and it worked within a fortnight.

Last edited: Feb 24, 2025 at 4:29 PM
26 24JenMemphis, pat_auckland, Dr.GastroMayo and 23 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register